GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » Price-to-Operating-Cash-Flow

Anxo Pharmaceutical Co (ROCO:6677) Price-to-Operating-Cash-Flow : (As of May. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-05-14), Anxo Pharmaceutical Co's share price is NT$45.80. Anxo Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.05. Hence, Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, Anxo Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 79.33. The lowest was 10.95. And the median was 20.06.

ROCO:6677's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.515
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Anxo Pharmaceutical Co's Cash Flow from Operations per share for the six months ended in Dec. 2023 was NT$0.08. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.05.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Anxo Pharmaceutical Co was -103.40% per year.

During the past 11 years, Anxo Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 194.50% per year. The lowest was -23.00% per year. And the median was 27.35% per year.


Anxo Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Anxo Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.22 22.47 15.22 19.29 -

Anxo Pharmaceutical Co Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.22 - 19.29 - -

Competitive Comparison of Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Anxo Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=45.80/-0.054
=

Anxo Pharmaceutical Co's Share Price of today is NT$45.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anxo Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Anxo Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Anxo Pharmaceutical Co (ROCO:6677) Business Description

Traded in Other Exchanges
N/A
Address
8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines